96
Views
0
CrossRef citations to date
0
Altmetric
Articles

Candida palmioleophila Carba14 is capable of degrading carbamazepine

, , , , , & show all
Pages 191-201 | Published online: 17 Oct 2023
 

Abstract

Carbamazepine is considered as an emerging pollutant since in aquatic environments is toxic for fish and difficult to degrade. The goal of this study was to isolate yeasts capable of degrading carbamazepine. A hospital wastewater sample was used as an inoculant to carry out three successive transfers in minimal mineral medium added with 50 mg L−1 of carbamazepine. The isolates were characterized by colonial and microscopic morphology. A yeast was identified by sequencing its ITS1-5.8S-ITS2 intergenic region and by constructing of a phylogenetic tree. A kinetics of carbamazepine degradation was done with an initial concentration of 150 mg L−1 and the residual drug was determined by HPLC-UV. A total of 12 isolates were obtained, one of them had the characteristics of yeast (Carba14), the others were bacteria. Yeast isolate Carba 14 grew at all concentrations of carbamazepine tested (50, 100, 150 and 200 mg L−1) and grew better than bacterial isolates. This isolate degraded carbamazepine with an efficiency of 30% within 25 days. Yeast isolate Carba 14 was identified as Candida palmioleophila Carba 14. Our study shows for the first time the isolation of C. palmioleophila Carba 14 with potential to degrade carbamazepine.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by Instituto Politécnico Nacional (IPN), Secretaría de Investigación y Posgrado (SIP) grants 20220781 and 20230286. This work was carried out during the sabbatical year granted by the IPN to JJR, who is grateful for this support provided. JJR and JACM are grateful for the support provided by IPN through the EDI and COFAA sponsorships and for the SNI-CONACYT award. In addition, the scholarships CONACYT (1032775) and SIP-BEIFI awarded to AATT.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.